GLP1R and hypertensive disorder: In addition, the intervention of CB‐GLP‐1 improved the gut microbiota disorder caused by hypertension, suggesting that CB‐GLP‐1 may regulate the gut microbiota through the probiotic properties of the host bacterium CB, further suggesting that another mechanism of CB‐GLP‐1 treatment of hypertension is the regulation of the gut microbiota through the host bacterium CB (Figure 5).